ARTICLE | Company News
Novartis receives approval, approvable letter
September 22, 2000 7:00 AM UTC
Japan granted marketing approval to Novartis (SWX:NOVN; NVS) for its Diovan valsartan angiotensin receptor blocker to treat hypertension. NOVN plans to launch the product by year end. Also, NOVN recei...